BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27835578)

  • 1. Bioinformatics-Based Screening of Key LncRNAs for Modulating the Transcriptome Associated with Glaucoma in Human Trabecular Meshwork Cells.
    Guo J; Wu Y; Sun Y; Chen D; Huang Y; Shen X; Yan Z; Wang J
    Front Biosci (Landmark Ed); 2024 Feb; 29(3):91. PubMed ID: 38538254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA mediates stroke-induced neurogenesis.
    Fan B; Pan W; Wang X; Wei M; He A; Zhao A; Chopp M; Zhang ZG; Liu XS
    Stem Cells; 2020 Aug; 38(8):973-985. PubMed ID: 32346940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.
    Billingsley KJ; Manca M; Gianfrancesco O; Collier DA; Sharp H; Bubb VJ; Quinn JP
    Schizophr Res; 2018 Sep; 199():168-175. PubMed ID: 29501388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation.
    Sui B; Chen D; Liu W; Wu Q; Tian B; Li Y; Hou J; Liu S; Xie J; Jiang H; Luo Z; Lv L; Huang F; Li R; Zhang C; Tian Y; Cui M; Zhou M; Chen H; Fu ZF; Zhang Y; Zhao L
    Genome Biol; 2020 Sep; 21(1):228. PubMed ID: 32873321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative pathway enrichment analysis of multivariate omics data.
    Paczkowska M; Barenboim J; Sintupisut N; Fox NS; Zhu H; Abd-Rabbo D; Mee MW; Boutros PC; ; Reimand J;
    Nat Commun; 2020 Feb; 11(1):735. PubMed ID: 32024846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
    Chen Z; Shi X; Guo L; Li Y; Luo M; He J
    Oncotarget; 2017 Jan; 8(1):1944-1952. PubMed ID: 27911867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition.
    Egan B; Yuan CC; Craske ML; Labhart P; Guler GD; Arnott D; Maile TM; Busby J; Henry C; Kelly TK; Tindell CA; Jhunjhunwala S; Zhao F; Hatton C; Bryant BM; Classon M; Trojer P
    PLoS One; 2016; 11(11):e0166438. PubMed ID: 27875550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrently deregulated lncRNAs in hepatocellular carcinoma.
    Yang Y; Chen L; Gu J; Zhang H; Yuan J; Lian Q; Lv G; Wang S; Wu Y; Yang YT; Wang D; Liu Y; Tang J; Luo G; Li Y; Hu L; Sun X; Wang D; Guo M; Xi Q; Xi J; Wang H; Zhang MQ; Lu ZJ
    Nat Commun; 2017 Feb; 8():14421. PubMed ID: 28194035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle.
    Zhu H; Zhang L; Yan S; Li W; Cui J; Zhu M; Xia N; Yang Y; Yuan J; Chen X; Luo J; Chen R; Xing R; Lu Y; Wu N
    Oncotarget; 2017 Jan; 8(5):7867-7877. PubMed ID: 27999202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of non-coding RNA in ginseng rusty root symptom tissue.
    Bian X; Yu P; Dong L; Zhao Y; Yang H; Han Y; Zhang L
    Sci Rep; 2021 Apr; 11(1):9211. PubMed ID: 33911151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells.
    Wang M; Li J; Zuo Z; Ren C; Tang T; Long C; Gong Y; Ye F; Wang Z; Huang J
    J Cell Commun Signal; 2021 Jun; 15(2):237-250. PubMed ID: 33058043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma.
    Chen X; Li W; Xiao L; Liu L
    Int J Clin Exp Pathol; 2019; 12(4):1233-1247. PubMed ID: 31933938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking uterine enhancer of zeste homolog 2 have transcriptomic changes associated with uterine epithelial proliferation.
    Mesa AM; Mao J; Nanjappa MK; Medrano TI; Tevosian S; Yu F; Kinkade J; Lyu Z; Liu Y; Joshi T; Wang D; Rosenfeld CS; Cooke PS
    Physiol Genomics; 2020 Feb; 52(2):81-95. PubMed ID: 31841397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome sequencing of lncRNA, miRNA, mRNA and interaction network constructing in coronary heart disease.
    Liao J; Wang J; Liu Y; Li J; Duan L
    BMC Med Genomics; 2019 Aug; 12(1):124. PubMed ID: 31443660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.
    Li Y; Luo M; Shi X; Lu Z; Sun S; Huang J; Chen Z; He J
    Oncotarget; 2016 Dec; 7(49):81715-81726. PubMed ID: 27835578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
    Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
    J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.